Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIMCERE PHARMA

12.480
+0.2201.79%
Volume:17.69M
Turnover:216.01M
Market Cap:31.03B
PE:39.18
High:12.620
Open:12.260
Low:11.840
Close:12.260
Loading ...
OverviewCompanyNewsFilings

Simcere Pharmaceutical- Under Deal Co to Receive Upfront Payment From Abbvie, Eligible to Receive Option Fees & Milestone Payments of up to $1.055 Bln

THOMSON REUTERS
·
13 Jan

Simcere Pharma Gets Clinical Trial Nod in China for Anti-Tumor Drug

MT Newswires Live
·
06 Jan

BRIEF-Simcere Pharmaceutical Says Clinical Trial Approval For SIM0505 Issued By NMPA

Reuters
·
06 Jan

Simcere Pharmaceutical - Clinical Trial Approval for Sim0505 Issued by Nmpa

THOMSON REUTERS
·
06 Jan

Simcere Pharmaceutical Group Renews Key Agreements

MT Newswires Live
·
24 Dec 2024

Analyst Rate

Buy
Buy
83.33%
Hold
16.67%
Sell
0.00%

Corporate Actions

Ex-dividend Date
Jun 18, 2025 Dividend Per Share 0.16 CNY
Financial Report Announcement
Mar 24, 2025 Post Market
Financial Report Announcement
Aug 21, 2024 Post Market
Ex-dividend Date
Jun 18, 2024 Dividend Per Share 0.1757 HKD
Financial Report Announcement
Mar 20, 2024

Dividend History

Ex-DateDividend
2021-06-290.18031
2022-06-280.176025
2023-06-190.17576
2024-06-180.1757
2025-06-180.16

Valuation Analysis

38.51
Current
14.83
Sector Average
97.27%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
38.51
Maximum
45.00
+1 STD
28.77
Minimum
-16.73
-1 STD
0.89
Average
14.83

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.